Lamotrigin Abz (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels, which prolongs the inactivated state of the channel and reduces neuronal firing. This stabilizes neuronal membranes and decreases the release of excitatory neurotransmitters such as glutamate, helping to prevent seizure activity and contribute to mood stabilization in bipolar disorder.

The appropriate dose of Lamotrigin Abz is determined by the prescribing clinician based on the patient’s specific condition, age, weight, and response to therapy. Dosage titration is typically individualized to balance efficacy with safety, and patients should follow the prescriber’s instructions without self‑adjusting the dose.

Safety data for lamotrigine in pregnancy and lactation are limited, and the drug should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To request Lamotrigin Abz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Lamotrigine differs from many antiepileptics by primarily targeting voltage‑gated sodium channels and having a relatively favorable side‑effect profile, especially regarding cognitive function. Compared with agents such as carbamazepine or phenytoin, lamotrigine often requires slower titration to minimize rash risk, but it offers efficacy for both focal and generalized seizures and mood stabilization in bipolar disorder.

Lamotrigin Abz should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, direct sunlight, and excessive heat. Do not refrigerate or freeze the product, as temperature extremes may affect its stability.

Lamotrigin Abz is administered orally, typically as a tablet taken with or without food. The exact dosing schedule, including the initial dose and titration increments, is determined by the prescriber based on the patient’s clinical response and tolerance.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome and toxic epidermal necrolysis, which require immediate discontinuation of the drug. Other critical concerns are aseptic meningitis, blood dyscrasias like agranulocytosis, and rare cases of hepatotoxicity. Patients should be instructed to report any rash or systemic symptoms promptly.

Lamotrigin Abz should be avoided in individuals with known hypersensitivity to lamotrigine or any of its excipients. Caution is also advised for patients with severe hepatic impairment, those taking interacting medications that markedly increase lamotrigine levels (e.g., valproic acid), and pregnant women unless the benefits outweigh the risks.